UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033830
Receipt number R000038586
Scientific Title Randomized control trial between OPB-2045G and PVI
Date of disclosure of the study information 2019/10/01
Last modified on 2021/06/04 11:36:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized control trial between OPB-2045G and PVI

Acronym

RCT between OPB and PVI

Scientific Title

Randomized control trial between OPB-2045G and PVI

Scientific Title:Acronym

RCT between OPB and PVI

Region

Japan


Condition

Condition

Patients undergoing operation with intestinal opening

Classification by specialty

Gastrointestinal surgery Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

OPB can reduce the rate of SSI.

Basic objectives2

Others

Basic objectives -Others

subgroup analysis

Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase III


Assessment

Primary outcomes

the rate of SSI

Key secondary outcomes

Influent factors of SSI
analysis of bacteria inducing SSI


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

OPB-2045G

Interventions/Control_2

PVI

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients undergoing operation including intestinal opening and hepatectomy.

Key exclusion criteria

Patients disagreed.

Patients who may have allergy for this drug.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Akira
Middle name
Last name Umemura

Organization

Morioka Municipal Hospital

Division name

Department of Surgery

Zip code

020-0866

Address

5-15-1 Motomiya, Morioka

TEL

019-635-0101

Email

aumemura@iwate-med.ac.jp


Public contact

Name of contact person

1st name Akira
Middle name
Last name Umemura

Organization

Morioka Municipal Hospital

Division name

Department of Surgery

Zip code

020-0866

Address

5-15-1 Motomiya, Morioka city

TEL

019-635-0101

Homepage URL


Email

aumemura@iwate-med.ac.jp


Sponsor or person

Institute

Morioka Municipal Hospital
Department of Surgery

Institute

Department

Personal name



Funding Source

Organization

Morioka Municipal Hospital
Department of Surgery

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Department of Surgery, Morioka Municipal Hospital

Address

5-15-1 Motomiya Morioka

Tel

019-635-0101

Email

aumemura@iwate-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

盛岡市立病院 外科


Other administrative information

Date of disclosure of the study information

2019 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 07 Month 01 Day

Date of IRB

2018 Year 06 Month 30 Day

Anticipated trial start date

2018 Year 07 Month 01 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry

2021 Year 03 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

under analyzing


Management information

Registered date

2018 Year 08 Month 21 Day

Last modified on

2021 Year 06 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038586


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name